Healthcare Innovations, 2
Back to All Secondary TrustsPortfolio Holdings by Security (As of Deposit Date)
Ticker | Security Description | Deposit % |
---|---|---|
ACAD | ACADIA Pharmaceuticals Inc. | 2.78 |
ACOR | Acorda Therapeutics, Inc. | 3.04 |
AGIO | Agios Pharmaceuticals, Inc. | 4.07 |
ALDR | Alder BioPharmaceuticals, Inc. | 3.41 |
ALKS | Alkermes plc | 3.40 |
ALNY | Alnylam Pharmaceuticals, Inc. | 1.93 |
ALXN | Alexion Pharmaceuticals, Inc. | 3.42 |
ARIA | ARIAD Pharmaceuticals, Inc. | 3.82 |
AXON | Axovant Sciences Ltd. | 3.05 |
BMRN | BioMarin Pharmaceutical Inc. | 3.19 |
CEMP | Cempra, Inc. | 3.68 |
DBVT | DBV Technologies S.A. | 3.66 |
FGEN | FibroGen, Inc. | 3.41 |
FPRX | Five Prime Therapeutics, Inc. | 3.51 |
HZNP | Horizon Pharma plc | 3.72 |
JAZZ | Jazz Pharmaceuticals plc | 3.55 |
KITE | Kite Pharma, Inc. | 3.07 |
LXRX | Lexicon Pharmaceuticals, Inc. | 3.30 |
MDCO | The Medicines Company | 3.59 |
NBIX | Neurocrine Biosciences, Inc. | 3.20 |
PBYI | Puma Biotechnology, Inc. | 3.17 |
PCRX | Pacira Pharmaceuticals, Inc. | 3.23 |
PRTA | Prothena Corporation plc | 3.65 |
PTLA | Portola Pharmaceuticals, Inc. | 3.35 |
RARE | Ultragenyx Pharmaceutical Inc. | 3.30 |
SGEN | Seattle Genetics, Inc. | 3.55 |
SRPT | Sarepta Therapeutics, Inc. | 6.43 |
VRTX | Vertex Pharmaceuticals Incorporated | 3.14 |
XLRN | Acceleron Pharma Inc. | 3.38 |
Health Care
Ticker | Security Description | Deposit % |
---|---|---|
ACAD | ACADIA Pharmaceuticals Inc. | 2.78 |
XLRN | Acceleron Pharma Inc. | 3.38 |
ACOR | Acorda Therapeutics, Inc. | 3.04 |
AGIO | Agios Pharmaceuticals, Inc. | 4.07 |
ALDR | Alder BioPharmaceuticals, Inc. | 3.41 |
ALXN | Alexion Pharmaceuticals, Inc. | 3.42 |
ALKS | Alkermes plc | 3.40 |
ALNY | Alnylam Pharmaceuticals, Inc. | 1.93 |
ARIA | ARIAD Pharmaceuticals, Inc. | 3.82 |
AXON | Axovant Sciences Ltd. | 3.05 |
BMRN | BioMarin Pharmaceutical Inc. | 3.19 |
CEMP | Cempra, Inc. | 3.68 |
DBVT | DBV Technologies S.A. | 3.66 |
FGEN | FibroGen, Inc. | 3.41 |
FPRX | Five Prime Therapeutics, Inc. | 3.51 |
HZNP | Horizon Pharma plc | 3.72 |
JAZZ | Jazz Pharmaceuticals plc | 3.55 |
KITE | Kite Pharma, Inc. | 3.07 |
LXRX | Lexicon Pharmaceuticals, Inc. | 3.30 |
MDCO | The Medicines Company | 3.59 |
NBIX | Neurocrine Biosciences, Inc. | 3.20 |
PCRX | Pacira Pharmaceuticals, Inc. | 3.23 |
PTLA | Portola Pharmaceuticals, Inc. | 3.35 |
PRTA | Prothena Corporation plc | 3.65 |
PBYI | Puma Biotechnology, Inc. | 3.17 |
SRPT | Sarepta Therapeutics, Inc. | 6.43 |
SGEN | Seattle Genetics, Inc. | 3.55 |
RARE | Ultragenyx Pharmaceutical Inc. | 3.30 |
VRTX | Vertex Pharmaceuticals Incorporated | 3.14 |
Summary
Description
-
Trust Name Healthcare Innovations, 2
-
Trust Symbol SMHCBX
Deposit Data
-
Deposit Date 11/02/2016
-
Termination Date 20181101
-
Minimum Investment 100
-
Distribution Frequency Monthly (if any)
-
Initial Public Offer Price $10.00
-
Historical 12-Month Dist.* 0.00
CUSIP
-
Cash Cusip 83185R103
-
Reinvest Cusip 83185R111
-
Fee Cash Cusip 83185R129
-
Fee Invest Cusip 83185R137
Documents
*The Historical 12-Month Distribution of Trust Holdings is as of 10/01/2024. If the Trust deposited after, or 90 days prior to, 10/01/2024, the distribution is as of deposit date. The Historical 12-Month Distribution is calculated by taking the weighted average of the regular income distributions paid by the securities included in the trust’s portfolio over the 12 months preceding the trust’s date of deposit reduced to account for the effects of trust fees and expenses. This historical distribution is for illustrative purposes only and is not indicative of amounts that will actually be distributed by the trust. The distributions paid by the trust may be higher or lower than the amount shown above due to factors including, but not limited to, changes in the price of trust units, changes (including reductions) in distributions paid by issuers, changes in actual trust expenses and sales of securities in the portfolio. There is no guarantee that the issuers of the securities included in the trust will pay any distributions in the future.